Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2001
11/01/2001WO2001081310A1 1-aroyl-piperidinyl benzamidines
11/01/2001WO2001081308A2 Aminopiperidines for use as glyt-1 inhibitors
11/01/2001WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001WO2001042231A3 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors
11/01/2001WO2001029025A3 Tyrosine kinase inhibitors
11/01/2001US20010037025 Benzopyran, benzothiopyran or benzoquinone derivatives are useful in the treatment of ailments and disorders where a reduction of blood glucose is benefical, such as diabetes
11/01/2001US20010037023 Alkyl pyrimidines substituted piperidine derivatives are used as tachykinin antagonsit, useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorder, inflammation, and neurological disorders
11/01/2001US20010037022 Trisaryl-1,3,5-triazine ultraviolet light absorbers
11/01/2001CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001CA2407093A1 Substituted phenyl farnesyltransferase inhibitors
11/01/2001CA2406652A1 Aminopiperidines for use as glyt-1 inhibitors
11/01/2001CA2399741A1 4-hydroxycinnoline-3-carboxyamides as antiviral agents
11/01/2001CA2372673A1 Cyclic amidine compounds
10/2001
10/31/2001EP1149834A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
10/31/2001EP1149094A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors
10/31/2001EP1149093A1 4-aryloxindoles as inhibitors of jnk protein kinases
10/31/2001EP1149092A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149087A1 Piperidine, tetrahydropyridine and piperazine derivatives, their preparation and use
10/31/2001EP1149085A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1148880A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1066281B1 Cationic methylenedioxy benzenes, their use for oxidation dyeing of keratin fibres, dyeing compositions and methods
10/31/2001EP0773929B1 Piperidine derivatives as neurokinin antagonists
10/31/2001EP0719258B1 Cyclic amide derivatives for protecting against ultraviolet rays
10/31/2001EP0688317B1 Process for preparing acryl-piperidine carbinols
10/31/2001EP0624160B1 2-isocephem and oxacephem derivatives, processes for their preparation, intermediates thereof and use as antibacterial agents
10/31/2001CN1320121A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320118A Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
10/31/2001CN1320037A Antiviral indoleoxoacetyl piperazine derivatives
10/31/2001CN1319594A Diazesuberane derivant or its salt
10/31/2001CN1074013C 3-arylbenzofuranones as stabilisers and its use
10/31/2001CN1073988C Substituted N-heteroaroylguanidin, preparation, pharmaceutical application and medicine containg same
10/30/2001US6310211 8-hydroxy-7-substituted quinolines as anti-viral agents
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310079 Non-steroidal antiinflammatory agents
10/30/2001US6310077 Alkylating substituted benzofurancarboxamide with 1-chloro-3-methoxypropane in solvent in presence of base or acylating 1-(3-methoxypropyl)-4-piperidinamine with substituted benzofurancarboxylic acid, forming salt if desired
10/30/2001US6310076 Dihydropyridines and new uses thereof
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310067 Urocanic acid derivatives
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001CA2216160C Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/30/2001CA2074723C Pyridylphenyl nitrogen heterocycle-substituted carbinols and derivatives thereof with anti-inflammatory activity
10/30/2001CA2048027C 3-arylindole and 3-arylindazole derivatives
10/25/2001WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001WO2001079187A2 Substituted 1,4-thiazepine and analogs and their use as activators of caspases
10/25/2001WO2001079180A2 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001WO2001079167A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001WO2001078734A1 Methods of treatment
10/25/2001WO2001078723A1 Compounds and methods
10/25/2001WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001WO2001022950A3 Diosolane nucleoside analogs for the treatment or prevention of viral infection
10/25/2001WO2001019798A3 Inhibitors of factor xa
10/25/2001WO2000061541A8 Pharmaceutical compounds
10/25/2001US20010034448 New compounds, their preparation and use
10/25/2001US20010034445 Compounds such as 3-(3,4-Dihydro-8-((((6-amino2-pyridinyl) methyl)methylamino)carbonyl)-1-methyl-2,5-dioxo-1h-1,4-benzo diazepine)4-propanoic acid used as antiinflammatories, anticarcinogenics, and to treat angiogenesis, restenosis, etc
10/25/2001US20010034362 Pyrrolidine derivatives for vision and memory disorders
10/25/2001US20010034352 Cardiovascular disorders
10/25/2001US20010034351 A quinazoline compound
10/25/2001US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001US20010034343 Crohn's diseas, antiulcer agents, asthma, emesis
10/25/2001DE10020899A1 New 9-oxa-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001DE10020517A1 New 13-halo or cyano-epothilone derivatives, are phase-specific cell division regulators useful for treating malignant tumors, angiogenesis or inflammatory disease
10/25/2001CA2406475A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/25/2001CA2406271A1 Substituted 1,4-thiazepine and analogs and their use as activators of caspases
10/25/2001CA2405696A1 5-substituted tetralones as inhibitors of ras farnesyl transferase
10/25/2001CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/24/2001EP1148053A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
10/24/2001EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents
10/24/2001EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001EP1147094A1 Non-peptide glp-1 agonists
10/24/2001EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001EP1147088A1 6-arylphenanthridines with pde-iv inhibiting activity
10/24/2001EP1147083A1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
10/24/2001EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001EP1146871A1 Antidepressant heterocyclic compounds
10/24/2001EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001EP0854721B1 Endothelin receptor antagonists
10/24/2001EP0731801B1 Substituted aminoalkylaminopyridines
10/24/2001EP0685478B1 Quinoline derivatives
10/24/2001CN1319100A Isoquinoline derivatives with angiogenesis inhibiting activity
10/24/2001CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001CN1319094A Imidazolyl derivatives
10/24/2001CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001CN1319086A Anthranilic acid derivatives
10/24/2001CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/23/2001US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001US6307056 Inhibit or modulate protein kinases, in particular jnk protein kinases.
10/23/2001US6307051 2-alkylidene hydroxycoumaranone derivatives
10/23/2001US6307047 Prostaglandin endoperoxide H synthase biosynthesis inhibitors
10/23/2001US6306950 Improving the heat resistance of the title resin by including titanium dioxide having a zinc content of <0.1%; also includes an impact modifier, a stabilizer and a lubricant; pipes for conveying hot water; extrusion; discoloration inhibition
10/23/2001US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
10/23/2001US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001US6306864 Cerebral deficits subsequent to or resulting from cardiac bypass surgery and grafting, stroke, cerebral ischemia, spinal cord trauma, head trauma
10/23/2001US6306860 2,5-pyridinedicarboxylic acid derivatives
10/23/2001US6306852 Indole derivatives useful as endothelin receptor antagonists
1 ... 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 ... 694